Global Biophotonics Market is valued at USD 53.28 Billion in 2020 and expected to reach USD 109.23 Billion by 2027 with the CAGR of 10.8% over the forecast period
The increasing geriatric population is the major growth factor of the Global Biophotonics Market.
Biophotonics is a multidisciplinary research area acceptance all light-based technologies applied to the life sciences and medicine. It is used for the development of techniques that complement the range of current imaging and therapeutic techniques in common clinical use. It is alarmed with the use of light, in the visible for purpose of reviewing biological tissue, cells and molecules. Biophotonics Technics is used for examining molecular mechanism, function, and structure in biology. Biophotonics technique is used in different applications like Spectroscopy, Photomechanics, and Fiber optic sensors.
Global Biophotonics market report is segmented on the basis of end-use, application, and regional & country level. Based on end-Use, global biophotonics market is classified as tests and components, medical therapeutics, medical diagnostics and non-medical applications. Based on application, global biophotonics market is classified as see-through imaging, microscopy, inside imaging, Spectro molecular, another analytics sensing, light therapy, surface imaging and biosensors.
Global Biophotonics Market report covers prominent players like,
The increasing population of elderly patients is the major driving factor of global biophotonics market growth. In recent years, increasing health-related problems are also supplementing the market growth. Biophotonics is advanced in a number of fields like a laser, imaging technology and etc. In addition, improving imaging and therapeutic procedures that are commonly set for clinical purposes, including advances in lasers, optics, and fluorescence detectors is also augmenting the market growth. Biophotonics technique is used in the research of cancer cell. Furthermore, Due to the rapidly increasing number of cancer patients globally increases the demand for biophotonics. However, high equipment cost and lack of skilled professionals are the restraining factors of the biophotonics market. Moreover, increasing research on cancer treatment methods can be an opportunity for the further growth of global biophotonics market.
North America is expected to dominate the global biophotonics market due to the government’s initiatives, favorable healthcare infrastructure, and increased investment in R&D activities to develop the industry. Additionally, the increasing prevalence of chronic diseases like cancer, Alzheimer's disease is also fostered biophotonics market growth in this region. The Asia Pacific is an emerging market in biophotonics. Increasing awareness about chronic disease is the major factor that boosts the biophotonics market. For example, Among the 15 Asian countries the highest incidence rates for total cancer in males, whereas female total cancer incidence rates are highest. These factors are boosting the biophotonics market in this region.
The Middle East and Africa
|Historical data||2015 - 2020|
|Forecast Period||2021 - 2027|
|Market Size in 2020:||USD 53.28 Billion in 2020|
|Base year considered||2020|
|Forecast Period CAGR %:||
|Market Size Expected in 2027:||USD 109.23 Billion by 2027|
|Tables, Charts & Figures:||175|
|Biophotonics Companies:||IPG Photonics Corp., Idex Corp., Toshiba, Procter & Gamble, Horiba, Precision Photonics Corp., Roche, GE, Philips, Danone, Affymetrix, Inc., Andor Technology Ltd, Becton, Dickinson & Co, Carl Zeiss AG, FEI Company, Hamamatsu Photonics K.K., Lumenis Ltd., Olympus Corp., PerkinElmer Inc., Zecotek Photonics Inc., others.|
|Segments Covered||By End-User, By Application|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|